Possible association between circulating vascular endothelial growth factor and oxidative stress markers in hemodialysis patients

Medical Science Monitor

Volumn 12, Issue 4, 2006, Pages

  Pawlak, Krystyna ^a,b   Pawlak, Dariusz ^a   Myśliwiec, Michał ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Department of Nephrology and Clinical Transplantation ^*  (Poland)

Author keywords

Atherosclerosis; Cardiovascular disease; Hemodialysis; Oxidative stress; VEGF

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; COPPER ZINC SUPEROXIDE DISMUTASE; OXIDIZED LOW DENSITY LIPOPROTEIN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; MALE; OXIDATIVE STRESS;

ADULT; ATHEROSCLEROSIS; AUTOANTIBODIES; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; OXIDATIVE STRESS; RENAL DIALYSIS; SUPEROXIDE DISMUTASE; UREMIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33645537879     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Amann K, Ritz C, Adamczak M, Ritz E: Why is coronary heart disease of uraemic patients so frequent and so devastating? Nephrol Dial Transplant 2003: 18: 631-40
2. Boaz M, Green M, Fainauru M, Smetana S: Oxidative stress and cardiovascular disease in hemodialysis. Clin Nephrol, 2001;55: 93-100
3. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM: The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int, 2002; 62: 1524-38
4. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 1993; 362: 801-9
5. Chen Y-X, Nakashima Y, Tanaka K et al: Immunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimas of human coronary arteries. Arterioscler Thromb Vasc Biol, 1999; 19: 131-39
6. Inoue M, Itoh H, Ueda M et al: Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation, 1998; 98: 2108-16
7. Ramos MA, Kuzuya M, Esaki T et al: Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol, 1998; 18: 1188-96
8. Griendling KK, Alexander RW: Oxidative stress and cardiovascular disease. Circulation, 1997; 96: 3264-65
9. Khatri JJ, Johnson C, Magid R et al: Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma. Circulation, 2004; 109: 520-25
10. Pawlak K, Borawski J, Naumnik B, Myśliwiec M: Relationship between oxidative stress and extrinsic coagulation pathway in haemodialyzed patients. Thromb Res, 2003; 109: 247-51
11. Pawlak K, Naumnik B, Brzósko S et al: Oxidative stress - a link between endothelial injury, coagulation activation and atherosclerosis in haemodialysis patients. Am J Nephrol, 2004; 24: 154-61
12. Pawlak K, Pawlak D, Myśliwiec M: Oxidative stress influence CC-chemokines levels in hemodialyzed patients. Nephron Physiol, 2004; 96: 105-12
13. Pawlak K, Pawlak D, Myśliwiec M: Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease. Clin Biochem, 2005; 38: 700-5
14. Ishizuka T, Hayashi T, Nakazawa H et al: Serum vascular endothelial growth factor is a candidate biomarker of renal cell carcinoma in hemodialysis patients. Nephron, 2000; 84: 83-84
15. Eizawa T, Murakami Y, Matsui K et al: Circulating endothelial progenitor cells are reduced in hemodialysis patients. Curr Med Res Opin, 2003; 19: 627-33
16. El-Gendi H, Violaris AG, Foale R et al: Endogenous, local, vascular endothelial growth factor production in patients with chronic total coronary artery occlusions: further evidence for its role in angiogenesis. Heart, 2002; 87: 158-59
17. Roller RE, Renner W, Dorr A et al: Oxidative stress and increase of vascular endothelial growth factor in plasma of patients with peripheral arterial occlusive disease. Thromb Haemost, 2001; 85: 368
18. Cho M, Hunt TK, Hussain MZ: Hydrogen peroxide stimulates macrophage vascular endothelial growth factor release. Am J Physiol Heart Circ Physiol, 2001; 280: H2357-63
19. Ruef J, Hu ZY, Yin LY et al: Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis. Circ Res, 1997; 81: 24-33
20. Nespereira B, Perez-Ilzarbe M, Fernandez P et al: Vitamins C and E downregulate vascular VEGF and VEGFR-2 expression in apolipoprotein-E-deficient mice. Atherosclerosis, 2003; 171: 67-73
21. Kabayashi S, Inoue N, Azumi H et al: Expressional changes of the vascular antioxidant system in atherosclerotic coronary arteries. J Atheroscler Thromb, 2002; 9: 184-90
22. Yla-Herttuala S, Palinski W, Butle S et al: Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized low density lipoprotein. Atrerioscler Thromb, 1994; 14: 32-40
23. Inal M, Kanbak G, Sen S et al: Antioxidant status and lipid peroxidation in hemodialysis patients undergoing erythropoietin and erythropoietin-vitamin E combined therapy. Free Radic Res, 1999; 31: 211-16
24. Ludat K, Sommerburg O, Grune T et al: Oxidation parameters in complete correction of renal anemia. Clin Nephrol, 2000;53(Suppl.1): 30-35
25. del Peso G, Selgas R, Bajo MA et al: Serum level of vascular endothelial growth factor is influenced by erythropoietin treatment in peritoneal dialysis patients. Adv Perit Dial, 2000; 16: 85-89
26. Tsirpanlis G, Bagos P, Ioannou D et al: The variability and accurate assessment of microinflammation in haemodialysis patients. Nephrol Dial Transplant, 2004; 19: 150-57